Verma Priyanka, Biswas Sukla, Mohan Teena, Ali Shakir, Rao D N
Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Indian J Med Res. 2013 Dec;138(6):977-87.
BACKGROUND & OBJECTIVES: Despite major control efforts, malaria remains a major public health problem that still causes high mortality rate worldwide especially in Africa and Asia. Accurate and confirmatory diagnosis before treatment initiation is the only way to control the disease. The present study was undertaken to develop reagents using sandwich ELISA for simultaneous detection of PfHRP2 (Plasmodium falciparum histidine rich protein) and PfLDH (P. falciparum lactate dehydrogenase) antigens in the proven malaria cases.
The antibodies were raised against two epitopes of PfHRP2 protein and three unique and unexplored epitopes of PfLDH protein. These antibodies were able to detect PfHRP2 and PfLDH antigens in culture supernatant and parasitized RBC lysate of P. falciparum, respectively up to 50 parasites/μl. The in-house reagents were tested in 200 P. falciparum positive patients residing in Baghpat district of Uttar Pradesh in northern India.
Microsphere (PLGA) with CpG ODN were used to generate high titre and high affinity antibodies against selected peptides of PfHRP-2 and pLDH antigen in mice and rabbit. The peptide specific peak titre varied from 12,800 - 102,400 with an affinity ranging 0.73 - 3.0 mM. The indigenously developed reagents are able to detect PfHRP2 and PfLDH antigens as low as 75 parasites/μl of blood with a very high sensitivity (96-100%) and specificity (100%).
INTERPRETATION & CONCLUSIONS: The study highlight the identification of unique epitopes of PfHRP2 and PfLDH, and the generated antibodies against these antigens were used for quantitative estimation of these two antigens using sandwich ELISA. No corresreactivity with P. vivax infected patients was observed with the sera.
尽管采取了重大防控措施,但疟疾仍是一个主要的公共卫生问题,在全球尤其是非洲和亚洲仍导致高死亡率。在开始治疗前进行准确的确诊是控制该疾病的唯一途径。本研究旨在开发利用夹心酶联免疫吸附测定(ELISA)同时检测确诊疟疾病例中恶性疟原虫组氨酸丰富蛋白2(PfHRP2)和恶性疟原虫乳酸脱氢酶(PfLDH)抗原的试剂。
制备针对PfHRP2蛋白的两个表位以及PfLDH蛋白的三个独特且未被探索的表位的抗体。这些抗体能够分别在恶性疟原虫的培养上清液和寄生红细胞裂解物中检测到PfHRP2和PfLDH抗原,检测限可达每微升50个疟原虫。在印度北部北方邦巴格帕特地区居住的200例恶性疟原虫阳性患者中对自制试剂进行了检测。
使用带有CpG寡脱氧核苷酸(ODN)的微球(聚乳酸 - 羟基乙酸共聚物,PLGA)在小鼠和兔子体内产生针对PfHRP - 2和pLDH抗原选定肽段的高滴度和高亲和力抗体。肽段特异性峰值滴度在12,800 - 102,400之间,亲和力范围为0.73 - 3.0 mM。自主研发的试剂能够检测低至每微升血液75个疟原虫的PfHRP2和PfLDH抗原,具有非常高的灵敏度(96 - 100%)和特异性(100%)。
该研究突出了PfHRP2和PfLDH独特表位的鉴定,并且所产生的针对这些抗原的抗体被用于利用夹心ELISA对这两种抗原进行定量评估。未观察到与间日疟原虫感染患者血清有交叉反应。